These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6127349)

  • 1. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies.
    Pratt C; Lichstein E
    J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Aug; 60(6):10D-14D. PubMed ID: 2888297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias.
    Singh BN; Nademanee K
    Am Heart J; 1987 Oct; 114(4 Pt 2):1040-50. PubMed ID: 2444089
    [No Abstract]   [Full Text] [Related]  

  • 5. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric therapy with beta-blockers.
    Hjalmarson A
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):460-6. PubMed ID: 7513874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiac death, ventricular arrhythmias, and antiarrhythmic therapy: current trials and tribulations.
    Anderson JL
    Aust N Z J Med; 1986 Jun; 16(3):409-12. PubMed ID: 3535769
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of beta-blocker an as antiarrhythmic agent].
    Okazaki O; Akatsuka N
    Nihon Rinsho; 1996 Aug; 54(8):2117-24. PubMed ID: 8810786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia.
    Hirsowitz G; Podrid PJ; Lampert S; Stein J; Lown B
    Am Heart J; 1986 May; 111(5):852-60. PubMed ID: 2871739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
    Pratt CM; Théroux P; Slymen D; Riordan-Bennett A; Morisette D; Galloway A; Seals AA; Hallstrom A
    Am J Cardiol; 1987 Feb; 59(4):278-83. PubMed ID: 2880497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General principles of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Landers MD; Reiter MJ
    Am J Cardiol; 1997 Oct; 80(8A):31G-44G. PubMed ID: 9354410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta blockers as anti-arrhythmic agents.
    Anh D; Marine JE
    Heart Fail Rev; 2004 Apr; 9(2):139-47. PubMed ID: 15516862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of completed sudden death trials: US experience.
    Furberg CD
    Cardiology; 1987; 74 Suppl 2():24-31. PubMed ID: 2887288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.